Stocktoria

Park Ha Biological Technology Co., Ltd. BYAH

Park Ha Biological Technology Co., Ltd. financials (annual)

Revenue
$2.5M $2.4M $2.5M 202320242025
Net income
$852042 $478561 -$24.4M 202320242025
Free cash flow
202320242025

Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023
Revenue$2.5M$2.4M$2.5M
Gross profit$2.4M$2.2M$2.1M
R&D expense$238,184$36,714$30,881
Operating income-$24.1M$793,714$1.2M
Income tax$280,646$314,860$329,527
Net income-$24.4M$478,561$852,042
EPS (diluted)$-41.38$0.96$1.70
Operating cash flow$85,852$960,470$126,537
Cash & equivalents$3.8M$547,498$1.0M
Inventory$75,214$71,486$95,870
Total assets$6.0M$3.1M$2.3M
Total liabilities$2.0M$1.6M$1.3M
Shareholders' equity$4.0M$1.5M$1.0M

Growth · year-over-year · Revenue CAGR 1.3%

MetricFY2025FY2024FY2023
Revenue growth+6.0%-3.1%
Net income growth-5191.3%-43.8%
EPS growth-4410.4%-43.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.